Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior SystemGlobeNewsWire · Oct 14, 2026
Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire · Oct 2, 2026
Carlsmed Appoints Tony Jarc as Chief Product and AI OfficerGlobeNewsWire · Oct 1, 2026
Carlsmed Appoints Richard Heppenstall as Chief Financial OfficerGlobeNewsWire · Sep 28, 2026
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen MedicalGlobeNewsWire · Sep 15, 2026
Carlsmed, Inc. Announces Chief Operating Officer AppointmentGlobeNewsWire · Sep 8, 2026Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | -$0.40 | -$0.39 | Beat |
| May 5, 2026 | -$0.43 | -$0.32 | Beat |
| Feb 25, 2026 | -$0.43 | -$0.32 | Beat |
| Nov 6, 2025 | -$0.45 | -$0.40 | Beat |
| Aug 28, 2025 | -$1.52 | -$1.47 | Beat |
| Jun 26, 2025 | -$0.91 | -$1.39 | Miss |